Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Advanced Non-Small-Cell Lung Cancer
Clinical trial register · Taiwan

Advanced Non-Small-Cell Lung Cancer Trials in Taiwan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2865 matching records held by the registry are in this view. Synced 19 Nov 2026, 03:18 UTC
2865
Studies in scope
all four open statuses
1570
Recruiting now
open to new participants
340
Lead sponsors
across recruiting studies
Top sites
Taipei 9 Kaohsiung City 6 Tainan 6 Taichung 5 Taoyuan 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Advanced Non-Small-Cell Lung Cancer trials in Taiwan

9 of 2865 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer
Phase 3
1,410
Changhua County, Hsinchu, Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
2026-01-06
Recruiting
ArriVent BioPharma, Inc.
Phase 3
480
Kaohsiung City, Taichung, Taipei
2025-12-17
Active, closed
Regeneron Pharmaceuticals
Phase 2/3
149
Dalin, Hualien City, Kaohsiung City, New Taipei City, Tainan, Taipei
2023-06-30
Active, closed
ArriVent BioPharma, Inc.
Phase 3
398
Kaohsiung City, Taichung, Chang-hua, Tainan, Taipei
2023-06-01
Active, closed
Regeneron Pharmaceuticals
Phase 2
51
Kaohsiung City, New Taipei City, Taipei
2023-04-21
Active, closed
Gilead Sciences
Phase 2
400
Hualien City, Kaoshiung, New Taipei City, Taipei, Yunlin County
2023-02-21
Recruiting
Bayer
Phase 1/2
430
Taichung, Tainan, Taipei, Taoyuan
2021-10-25
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Taichung, Tainan, Taipei, Taoyuan
2020-12-02
Active, closed
AstraZeneca
Phase 1
344
Kaohsiung City, Tainan, Taipei
2014-08-05
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-taiwan/condition/advanced-non-small-cell-lung-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,865 studies in total at the last sync on 19 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies listing the condition Advanced Non-Small-Cell Lung Cancer.

How many Advanced Non-Small-Cell Lung Cancer trials are recruiting in Taiwan?

4 of the 9 studies on this page are recruiting new participants as of the 19 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Advanced Non-Small-Cell Lung Cancer), 9 studies
PhaseStudiesRecruitingShare
Phase 33233.3%
Phase 22022.2%
Phase 2/32122.2%
Phase 11011.1%
Phase 1/21111.1%

Most active sponsors

Lead sponsors with the most studies (Advanced Non-Small-Cell Lung Cancer)
Lead sponsorStudiesRecruiting
ArriVent BioPharma, Inc.21
Regeneron Pharmaceuticals20
AstraZeneca10
Bayer11
Gilead Sciences10
Mirati Therapeutics Inc.11
Pfizer11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.